Skip to Content

Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy (TNT)

In this MEDtalk from the ASCO GI conference, Dr. Yun Sung presents a study that evaluates survival outcomes for patients receiving TNT and gastric resection, including 203 patients, primarily treated with induction chemotherapy using 5-FU and oxaliplatin, followed by chemoradiation.

Yun Sung

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top